As the general counsel for Roche Molecular Solutions Inc., Kevin A. Marks takes his work home with him. His grandmother’s cancer treatments included a drug from the pharmacology division of Roche Holding AG, his employer’s parent company. His mother’s macular degeneration is being treated with products manufactured by Genentech Inc., a Roche subsidiary since 2009.
“There is a direct correlation between products that are ... (continued)